Authors: Szakacs, G Ozvegy, C Bakos, E Sarkadi, B Varadi, A

Citation: G. Szakacs et al., Role of glycine-534 and glycine-1179 of human multidrug resistance protein(MDR1) in drug-mediated control of ATP hydrolysis, BIOCHEM J, 356, 2001, pp. 71-75

Authors: Bakos, E Evers, R Sinko, E Varadi, A Borst, P Sarkadi, B

Citation: E. Bakos et al., Interactions of the human multidrug resistance proteins MRP1 and MRP2 withorganic anions, MOLEC PHARM, 57(4), 2000, pp. 760-768

Authors: Bakos, E Evers, R Calenda, G Tusnady, GE Szakacs, G Varadi, A Sarkadi, B

Citation: E. Bakos et al., Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1), J CELL SCI, 113(24), 2000, pp. 4451-4461

Authors: Szakacs, G Ozvegy, C Bakos, E Sarkadi, B Varadi, A

Citation: G. Szakacs et al., Transition-state formation in ATPase-negative mutants of human MDR1 protein, BIOC BIOP R, 276(3), 2000, pp. 1314-1319

Authors: Zehbe, I Ratsch, A Alunni-Fabbroni, M Burzlaff, A Bakos, E Durst, M Wilander, E Tommasino, M

Citation: I. Zehbe et al., Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions, ONCOGENE, 18(13), 1999, pp. 2201-2211

Authors: Varadi, A Tusnady, GE Bakos, E Sarkadi, B

Citation: A. Varadi et al., Membrane topology of the human multidrug resistance-associated protein (MRP) and its homologs, CYTOTECHNOL, 27(1-3), 1998, pp. 71-79